FDA Approves Jardiance to Reduce Cardiovascular Death

The US Food and Drug Administration (FDA) has approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease. ‘Cardiovascular disease is a leading cause of death in adults with type 2 diabetes mellitus,’ said Jean-Marc Guettier, MD, CM, Director of [...]

By |2016-12-13T14:40:29+00:00December 13th, 2016|Cardiology|Comments Off on FDA Approves Jardiance to Reduce Cardiovascular Death

NICE-Recommended Drug to Prevent Heart Attacks and Strokes

NICE has published draft guidance recommending anti-clotting drug ticagrelor 60mg with aspirin for people who have had a heart attack. In 2012/13 there were around 140,000 hospital admissions for heart attacks in England. Heart attacks and strokes are caused by the build-up of fatty material in artery walls to form a plaque. If the plaque [...]

By |2016-08-17T09:14:23+00:00August 17th, 2016|Cardiology|Comments Off on NICE-Recommended Drug to Prevent Heart Attacks and Strokes

New Link Discovered Between Aspirin Use and Stroke Risk

An international collaboration of scientists has carried out a large-scale study looking at whether the use of antithrombotic drugs such as aspirin and warfarin prior to a stroke leads to a better outcome. The team made up of academics from institutions from the UK, Canada and the US including the University of Aberdeen, University of [...]

By |2016-07-26T12:29:10+00:00July 27th, 2016|Cardiology|Comments Off on New Link Discovered Between Aspirin Use and Stroke Risk

Anabolic Steroid Abuse May Increase Risk of Abnormal Heart Rhythm and Stroke

Research has already shown that taking anabolic steroids is associated with high blood pressure and an increased risk of developing heart conditions, such as left ventricular hypertrophy (an enlarged heart). Now research, part-funded by the British Heart Foundation (BHF) and presented at this year’s British Cardiovascular Society (BCS) conference, has shown that for some people, misusing [...]

By |2016-06-13T09:06:35+00:00June 13th, 2016|Cardiology|Comments Off on Anabolic Steroid Abuse May Increase Risk of Abnormal Heart Rhythm and Stroke

Women with Migraines have Higher Risk of Heart Disease

The link between women with migraines and their increased risk of cardiovascular disease has been exposed in a new BMJ paper. Commenting on the research, Maureen Talbot, Senior Cardiac Nurse at the British Heart Foundation (BHF), said, ‘This large study of young women over a number of years, shows an association between migraine and an increased [...]

By |2016-06-01T14:04:11+00:00June 2nd, 2016|Cardiology|Comments Off on Women with Migraines have Higher Risk of Heart Disease

Study Points to Failures in Heart Attack Care in England and Wales

Around 33,000 deaths could have been avoided if heart attack aftercare guidelines outlining when to give treatment were followed, according to a study funded by the British Heart Foundation (BHF) and the National Institute for Health Research (NIHR), looking at the frequency of missed opportunities to treat people after a heart attack. A BHF-funded team [...]

By |2016-05-11T23:25:53+00:00May 12th, 2016|Cardiology|Comments Off on Study Points to Failures in Heart Attack Care in England and Wales

Statin Treatment Before Surgery Doesn’t Prevent Heart Damage

Giving daily doses of statins for a few days before and after heart surgery does not prevent heart muscle damage or the development of atrial fibrillation (AF), according to an international clinical trial led by the University of Oxford and funded by the British Heart Foundation (BHF). The trial, which is the largest of its [...]

By |2016-05-10T22:03:08+00:00May 11th, 2016|Cardiology|Comments Off on Statin Treatment Before Surgery Doesn’t Prevent Heart Damage

Guidance for New PCSK9 Inhibitors ‘Likely to Change’

NICE has published final draft guidance recommending two new treatment options for some people who have conditions that put them at extremely high risk of heart attacks or strokes. The British Heart Foundation (BHF) has responded to the news, stressing that further research into their long-term safety is needed before they are recommended more widely. [...]

By |2016-05-06T14:15:00+00:00May 6th, 2016|Cardiology|Comments Off on Guidance for New PCSK9 Inhibitors ‘Likely to Change’

New Heart Failure Drug to Prevent Deaths

Health authority NICE has recommended a new drug that could help transform the lives of people living in heart failure. Sacubiril valsartan is the first drug of its kind and will look to manage the symptoms of people in the UK with heart failure. In addition, it has the potential to reduce the more than 30,000 [...]

By |2016-04-27T15:11:17+00:00April 27th, 2016|Cardiology|Comments Off on New Heart Failure Drug to Prevent Deaths

Link Between Cardiovascular Disease and Aspirin Explained

The American College of Physicians has reviewed over 3,000 studies to evaluate whether or not taking aspirin decreases the risk of developing cardiovascular disease in adults aged 40 and over. Emily Reeve, Senior Cardiac Nurse at the British Heart Foundation (BHS), said, ‘If you have cardiovascular disease, particularly if you have experienced a heart attack [...]

By |2016-04-12T13:39:58+00:00April 12th, 2016|Cardiology|Comments Off on Link Between Cardiovascular Disease and Aspirin Explained